MedPath

Evaluation of the effects of cinchona supplementation on nutritional status and body composition in overweight/obese adults undergoing a hypocaloric diet

Not Applicable
Completed
Conditions
Overweight/obese adult subjects
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN13055163
Lead Sponsor
niversity of Naples Federico II
Brief Summary

2023 Results article in https://doi.org/10.3390/nu15245033 (added 13/12/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Patients aged 18–70 years
2. Overweight/Obese subjects (Body Mass Index 25-45 kg/m²)

Exclusion Criteria

1. Participation in other clinical studies
2. Weight change greater than 3 kg in the last 2 months
3. Cancer or diagnosis of cancer in the last 5 years
4. Acute or chronic inflammatory and metabolic diseases (e.g. Crohn's disease, rheumatoid arthritis, etc.)
5. Patients with type 1 or 2 diabetes, treated with insulin and oral hypoglycaemic drugs
6. Patients with type 2 diabetes, treated with diet alone, can be included in the study
7. Patients taking weight loss medications (e.g. sibutramine, orlistat, rimonabant) and/or history of bariatric surgery
8. Use of hormonal therapies (estrogen, thyroxine, progesterone)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath